Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation
Introduction
There is overwhelming evidence that obese individuals are more likely than their lean counterparts to develop cardiovascular disease, Type II diabetes, hypertension, hyperlipidemia, and hypercholesterolemia (Björntorp 1990). The increase in adiposity in these individuals results from an escalation in adipocyte number and an augmentation in size of individual fat cells. Additionally, the disproportionate increase in the visceral adipose deposits in some individuals is linked to development of certain metabolic disorders. The prevention and treatment of obesity has become a critical world health issue. In obese or overweight individuals, the differentiation of pre-adipocyte into mature adipocyte plays a major role in the development of obesity (Auwerx et al. 1996). Consequently, understanding the complex pathways and mechanisms regulating adipose formation should provide valuable information in the fight to combat the growing epidemic of obesity in the modern world. Differentiation of pre-adipocyte into adipose tissue requires several transcription factors and at the center of this network are the two principal adipogenic factors, CCAAT/enhance-binding proteins α (C/EBPα) (Lane et al. 1996) and peroxisome proliferator activated receptor γ (PPARγ) (Hamm et al. 1999) which oversee the entire terminal differentiation process. PPARγ, a nuclear hormone receptor, is of particular importance as it functions as a transcriptional regulator in adipose tissue controlling multiple genes involved in lipid and glucose metabolism (Lee et al. 2003). PPARγ is considered the master regulator of adipogenesis. Without it, precursor cells are incapable of expressing any known aspect of the adipocyte phenotype (Rosen et al. 2002). On the other hand, cells deficient in C/EBPα are capable of adipocyte differentiation. However, these C/EBPα-deficient cells are insulin resistant (El-Jack et al. 1999; Wu et al. 1999). Knowledge of this complex network and the importance of PPARγ and C/EBPα arise predominantly from studies performed in established pre-adipocyte cell lines. More recently, data from a variety of knockout mice have confirmed these in vitro studies showing that many components of this network are required as regulators of adipocyte development and function.
Berberine is a plant alkaloid with a long history of medicinal use in Chinese and Ayurvedic medicine. Berberine is present in the roots, rhizomes, and stem bark of seven plant families including Hydrastis canadensis (goldenseal), Coptis chinensis (coptis or goldenthread), Berberis aquifolium (Oregon grape), Berberis vulgaris (barberry), and Berberis aristata (tree turmeric). The chemical structure of berberine used in this study is shown in Fig. 1. Studies have shown that berberine possesses many and varied pharmacological properties and has potential use as an anti-cancer agent, as an antimicrobial and in lowering LDL (Anis et al. 2001; Huang and Williams 1999; Auwerx et al. 1992). Recent reports have shown berberine as a potential inhibitor of pre-adipocyte differentiation (Choi et al. 2006; Huang et al. 2006) and Huang et al. (2006) reported that the possible mechanism of inhibiting pre-adipocyte differentiation is related to down-regulation of the transcription factors C/EBPα and PPARγ.
It has been reported that the transcription factors GATA binding protein 2 and 3 (GATA-2 and GATA-3) are expressed in adipocyte precursors and control the pre-adipocyte to adipocyte transition. Studies show that constitutive expression of both GATA-2 and GATA-3 suppressed adipocyte differentiation (Tong et al. 2000). The mechanism is partially through direct binding to the peroxisome proliferators activated receptor γ (PPARγ) promoter and suppression of its basal activity. In addition, both GATA-2 and GATA-3 form protein complexes with CCAAT/enhancer binding protein α (C/EBPα) (Tong et al. 2005). However, whether the berberine can directly affect the expression of GATA-2 and 3 has not been investigated. In this study, we have examined the effects of berberine on the differentiation of 3T3-L1 cells and demonstrated that berberine increases GATA-2 and GATA-3 mRNA and protein expression accompanied by inhibited adipocyte differentiation.
Section snippets
Materials
3T3-L1 cells, Dulbecco's Modified Eagle's Medium (DMEM) were purchased from ATCC Global Bioresource Center, Fetal Bovine Serum (FBS) was purchased from Atlanta Biologicals Corp., Berberine chloride, Penicillin/streptomycin, Oil Red O, MTT, Isopropanol, Acrylamide/Bis-Acrylamide, DMSO, DNA size markers were purchased from Sigma Co., Trizol and Superscript One-Step RT-PCR kit were purchased from Invitrogen Life Technologies, Oligonucleotide primers were synthesized by Integrated DNA Technologies
Berberine has a minor effect on the viability of 3T3-L1 cells during proliferation and differentiation
MTT analysis was carried out at day 1, 2 and 3 of proliferation and during days 2, 4, 6 and 8 of differentiation to detect the effect of berberine on the viability of 3T3-L1 cells during proliferation (Fig. 2A) and differentiation (Fig. 2B). 3T3-L1 cells were treated with various concentrations of berberine (0, 1, 2, 4, 8, 16, 32, 64 μM) during each stage. Berberine had a small effect on cell viability during proliferation with 8 μM berberine only decreasing viability by 13.2%, 13.8% and 18.6%
Discussion
Adipocyte differentiation plays a crucial role in obesity (Giri et al. 2006). The mechanisms of adipocyte differentiation have been extensively studied in pre-adipocyte culture systems with key transcription factors involved in the complex transcriptional cascade that occurs during adipocyte differentiation being identified. These include the adipogenic PPARγ (Tontonoz et al. 1994) and members of the C/EBP family which are major regulators of metabolic gene expression (Davies et al. 2000; Ramji
Acknowledgements
We would like to thank Dr. Xiangming Guan, Dr. Shafiqur Rahman and Paige Kostboth for their critical review of this manuscript and Yong Zhao and Xiaoying Zhang for their technical advice.
This study was partly funded by a South Dakota Governor's 2010 Individual Research Seed Grant.
References (30)
- et al.
Modulation of PPAR activity via phosphorylation
Biochim. Biophys. Acta
(2007) - et al.
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
J. Lipid. Res.
(2006) - et al.
The ovine CCAAT-enhancer binding protein delta gene: cloning, characterization, and species-specific autoregulation
Biochem. Biophys. Res. Commun.
(2000) - et al.
Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors
J. Biol. Chem.
(2000) - et al.
Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARγ and C/EBPα
J. Biol. Chem.
(1999) - et al.
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Biochem. Biophys. Res. Commun.
(2006) - et al.
Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
Cell
(1994) - et al.
Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity
Mol. Cell.
(1999) - et al.
Inhibition of chemical carcinogenesis by berberine in rats and mice
J. Pharm. Pharmacol.
(2001) - et al.
Lipoprotein lipase: recent contributions from molecular biology
Crit. Rev. Clin. Lab. Sci.
(1992)
Transcription, adipocyte differentiation, and obesity
J. Mol. Med.
Obesity and adipose tissue distribution as risk factors for the development of disease: a review
Infusionstherapie
Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte
Exp. Mol. Med.
Tea catichin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ2 and C/EBPα in 3T3-L1 cells
Biosci. Biotechnol. Biochem.
AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model
Nutr. Metabol.
Cited by (52)
Antiobesity functional leads and targets for drug development
2019, Phytochemicals as Lead Compounds for New Drug DiscoveryThe influence of alkaloids on oxidative stress and related signaling pathways
2019, Free Radical Biology and Medicine